The Centers for Disease Control and Prevention (CDC) is conducting market research to identify small businesses capable of performing allergen-specific immunoglobulin E (IgE) testing as part of a future procurement initiative. The selected contractor will be required to analyze IgE levels from approximately 20,000 individuals, focusing on 21 specific allergens, while ensuring compliance with regulatory standards and maintaining participant confidentiality. This testing is crucial for providing national health statistics and insights into allergic diseases, particularly in response to changing environmental factors. Interested small businesses should submit a summary of their capabilities to Michael Gilham at ueh8@cdc.gov by 4 PM Eastern Time on October 21, 2024, as this is not a solicitation for a contract but a request for information.